[HTML][HTML] Long-term respiratory and neurological sequelae of COVID-19

F Wang, RM Kream, GB Stefano - Medical science monitor …, 2020 - ncbi.nlm.nih.gov
Since the initial reports of coronavirus disease 2019 (COVID-19) in China in late 2019,
infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have …

COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options

LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …

Short-and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan

S Kim, H Lee, J Lee, SW Lee, R Kwon, MS Kim… - Nature human …, 2024 - nature.com
We investigated whether SARS-CoV-2 infection is associated with short-and long-term
neuropsychiatric sequelae. We used population-based cohorts from the Korean nationwide …

[HTML][HTML] Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health

RL Doty - Trends in Molecular Medicine, 2022 - cell.com
Decreased smell function is related to brain health, future mortality, and quality of life. Most
people inflicted with the SARS-CoV-2 virus evidence some measurable smell dysfunction …

Long COVID and neuropsychiatric manifestations

V Efstathiou, MI Stefanou… - Experimental and …, 2022 - spandidos-publications.com
There is accumulating evidence in the literature indicating that a number of patients with
coronavirus disease 2019 (COVID‑19) may experience a range of neuropsychiatric …

The reciprocal interactions between microglia and T cells in Parkinson's disease: a double-edged sword

Y Xu, Y Li, C Wang, T Han, H Liu, L Sun, J Hong… - Journal of …, 2023 - Springer
In Parkinson's disease (PD), neurotoxic microglia, Th1 cells, and Th17 cells are
overactivated. Overactivation of these immune cells exacerbates the disease process and …

Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei

A Emmi, S Rizzo, L Barzon, M Sandre… - npj Parkinson's …, 2023 - nature.com
Neurological manifestations are common in COVID-19, the disease caused by SARS-CoV-
2. Despite reports of SARS-CoV-2 detection in the brain and cerebrospinal fluid of COVID …

Parkinson's disease and the COVID-19 pandemic

C Fearon, A Fasano - Journal of Parkinson's Disease, 2021 - content.iospress.com
Studies focusing on the relationship between severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19), and Parkinson's …

Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease

SN Rai, N Tiwari, P Singh, AK Singh… - Oxidative medicine …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …

A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population

B Brakedal, L Toker, K Haugarvoll, C Tzoulis - npj Parkinson's Disease, 2022 - nature.com
Epidemiological studies of Parkinson's disease (PD) show variable and partially conflicting
findings with regard to incidence, prevalence, and mortality. These differences are …